Lower Superoxide Dismutase 2 (SOD2) Protein Content in Mononuclear Cells Is Associated with Better Survival in Patients with Hemodialysis Therapy

Figure 1

(a) Detection of proteins SOD2 and reference protein beta-actin in monocytes by immunoblotting. (b) Representative in-cell Western assay for quantification of SOD2 protein content in monocytes from a healthy control subject (Healthy), a patient with chronic kidney disease (CKD), and a hemodialysis patient (HD). Upper panels show SOD2 protein content (red fluorescence); middle panels of beta-actin (green fluorescence) and lower panels show overlay. Fluorescence intensities were analyzed in quadruplicate for each sample.

(a)

(b)